HIF1A and cancer: Under hypoxic conditions, hypoxia-inducible factors (particularly HIF-1α) upregulate the expression of drug efflux pumps such as P-glycoprotein and multidrug resistance-associated proteins, which pump chemotherapeutic agents out of cancer cells, reducing intracellular drug accumulation and efficacy, thereby contributing to MDR 117.